Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Shanghai Pharmaceuticals Holding Co ( (HK:2607) ).
Shanghai Pharmaceuticals Holding Co., Ltd. issued a supplemental announcement regarding the upcoming extraordinary general meeting scheduled for March 13, 2025. The announcement clarifies the official English name of Dr. WAN Jun, a candidate for the independent non-executive director position, as Dr. WAN Jun MAN Kwan. The company assures stakeholders that the English version of the proxy form remains valid, and previous votes will be considered valid for the revised resolution.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. is a major player in the pharmaceutical industry in China, focusing on the production and distribution of a wide range of pharmaceutical products. The company is involved in the research, development, manufacturing, and sales of both prescription and over-the-counter drugs, catering to a diverse market segment.
YTD Price Performance: -5.52%
Average Trading Volume: 30,224
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $7.81B
For an in-depth examination of 2607 stock, go to TipRanks’ Stock Analysis page.